SecSonar.com

Trinity Biotech plc (TRIB)

Trinity Biotech plc at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Trinity Biotech plc (TRIB) is a Medical - Diagnostics & Research company based in IE with a market capitalization of $7.4M. Revenue declined 28.6% year-over-year and free cash flow was negative at -$6.3M. This page tracks TRIB's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

IE · 380 employees · IPO Oct 21, 1992

Valuation

Valuation & price

$0.60 · as of May 23, 2026 · -68.5% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

—

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$1.62$0.98$0.34Jul 25Dec 25Jul 26Jul 7, 25$0.73Jul 9, 25$0.75Jul 11, 25$0.79Jul 15, 25$0.71Jul 17, 25$0.73Jul 21, 25$0.72Jul 23, 25$0.73Jul 25, 25$0.67Jul 29, 25$0.67Jul 31, 25$0.69Aug 4, 25$0.82Aug 6, 25$0.83Aug 11, 25$0.83Aug 13, 25$1.01Aug 15, 25$1.62Aug 19, 25$1.37Aug 21, 25$1.56Aug 25, 25$1.55Aug 27, 25$1.48Aug 29, 25$1.46Sep 3, 25$1.33Sep 5, 25$1.16Sep 9, 25$1.10Sep 11, 25$1.20Sep 16, 25$1.20Sep 18, 25$1.21Sep 22, 25$1.20Sep 24, 25$1.14Sep 26, 25$1.07Sep 30, 25$1.04Oct 2, 25$1.06Oct 6, 25$1.10Oct 8, 25$1.06Oct 10, 25$1.05Oct 14, 25$1.07Oct 16, 25$1.02Oct 21, 25$0.96Oct 23, 25$0.95Oct 27, 25$1.02Oct 29, 25$0.99Oct 31, 25$1.00Nov 4, 25$1.00Nov 6, 25$0.96Nov 10, 25$0.94Nov 12, 25$0.90Nov 14, 25$0.88Nov 18, 25$0.82Nov 20, 25$0.83Nov 25, 25$0.89Nov 28, 25$1.05Dec 2, 25$1.01Dec 4, 25$1.00Dec 8, 25$1.10Dec 10, 25$1.14Dec 12, 25$1.07Dec 16, 25$0.95Dec 18, 25$0.94Dec 22, 25$0.89Dec 24, 25$1.02Dec 29, 25$0.82Jan 2, 26$0.75Jan 6, 26$0.76Jan 8, 26$0.74Jan 12, 26$0.71Jan 14, 26$0.70Jan 16, 26$0.69Jan 21, 26$0.70Jan 23, 26$0.91Jan 27, 26$0.94Jan 29, 26$0.88Feb 2, 26$0.82Feb 4, 26$0.78Feb 9, 26$0.80Feb 11, 26$0.82Feb 13, 26$0.77Feb 18, 26$0.76Feb 20, 26$0.71Feb 24, 26$0.75Feb 26, 26$0.72Mar 2, 26$0.69Mar 4, 26$0.70Mar 6, 26$0.73Mar 10, 26$0.65Mar 12, 26$0.69Mar 17, 26$0.74Mar 19, 26$0.65Mar 23, 26$0.60Mar 25, 26$0.61Mar 27, 26$0.60Mar 31, 26$0.54Apr 2, 26$0.60Apr 7, 26$0.61Apr 9, 26$0.70Apr 13, 26$0.70Apr 15, 26$0.70Apr 17, 26$0.75Apr 22, 26$0.70Apr 24, 26$0.64Apr 28, 26$0.61Apr 30, 26$0.60May 4, 26$0.62May 6, 26$0.60May 8, 26$0.61May 12, 26$0.59May 14, 26$0.58May 18, 26$0.57May 20, 26$0.60May 22, 26$0.60May 28, 26$0.70Jun 1, 26$0.72Jun 3, 26$0.70Jun 5, 26$0.67Jun 9, 26$0.66Jun 11, 26$0.68Jun 15, 26$0.68Jun 17, 26$0.58Jun 22, 26$0.58Jun 24, 26$0.34Jun 26, 26$0.36Jul 2, 26$0.38
$0.3452-week range$1.91
Loading valuation history…

Fundamentals

Key fundamentals

$7.4M

Market cap

-28.6%

Revenue growth (YoY)

35.4%

Gross margin

-$6.3M

Free cash flow (USD)

$132.8M

Net debt

3.4%

Share dilution

0/4

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$99.6MFY 2017$99.1MFY 2018$97.0MFY 2019$90.4MFY 2020$102.0MFY 2021$81.1MFY 2022$62.5MFY 2023$56.8MFY 2024$61.6MFY 2025$43.9M
$99.6M$43.9M

Free cash flow by year

2016 → 2025

FY 2016$-8.5MFY 2017$-4.3MFY 2018$-10.4MFY 2019$-9.9MFY 2020$13.6MFY 2021$4.5MFY 2022$-6.9MFY 2023$-12.4MFY 2024$-14.3MFY 2025$-6.3M
-$8.5M-$6.3M

Gross margin by year

2021 → 2025

FY 202141.2%FY 202235.3%FY 202334.2%FY 202434.8%FY 202535.4%
41.2%35.4%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: Jun 16, 2026 (EPS $-0.23)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Quarterly reportInterim Results (6-K)Jul 2, 2026Filing
  • Annual reportAnnual Report FiledJun 30, 2026Filing
  • Annual reportAnnual Report FiledJun 29, 2026Filing
  • Annual reportAnnual Report FiledJun 23, 2026Filing
  • Annual reportAnnual Report FiledJun 18, 2026Filing
  • 6-K filingAt The Market Offering AgreementJun 12, 2026Filing
  • Annual reportAnnual Report FiledJun 5, 2026Filing
  • Annual reportAnnual Report FiledMay 6, 2026Filing
  • Annual report20-F FiledApr 30, 2026Filing

Questions

Frequently asked questions

What is Trinity Biotech plc's market cap?

Trinity Biotech plc (TRIB) has a market capitalization of $7.4M.

What is TRIB's P/E ratio?

A meaningful P/E ratio is not available for TRIB — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

When did Trinity Biotech plc last report earnings?

TRIB last reported earnings on June 16, 2026; the next date is not yet scheduled.

Are insiders buying TRIB stock?

SEC Form 4 filings show no open-market insider buys at Trinity Biotech plc in the last 90 days (0 sells).

Same arena

Related companies in Medical - Diagnostics & Research

BIAF

bioAffinity Technologies, Inc.

$7.7M

NOTV

Inotiv, Inc.

$9.8M

BGLC

BioNexus Gene Lab Corp.

$4.4M

INBS

Intelligent Bio Solutions Inc.

$1.6M

ISPC

iSpecimen Inc.

$437K

VNRX

VolitionRx Limited

$15.6M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.